InsiderTrades

Form 4 for NRC NRC HEALTH

Accepted 2021-12-27 00:00:00 ET · period of report 2021-12-22 · accession 0001567619-21-022532 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-12-27 2021-12-22 NRC Hays Michael D. CEO, Pres, Dir F - Tax $40.07 -7,596 44.1K -15% -$304.4K
D 2021-12-27 2021-12-22 NRC Hays Michael D. CEO, Pres, Dir M - OptEx $10.75 +14.9K 51.7K +41% +$160.7K
DI 2021-12-27 2021-07-12 NRC Hays Michael D. CEO, Pres, Dir G - Gift $0.00 -10.5K 128.6K -8% $0
D 2021-12-27 2021-12-22 NRC Hays Michael D. CEO, Pres, Dir M - OptEx $0.00 -14.9K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-12-22 F D 7,596 $40.07 44,102 D — —
2 Common Common Stock 2021-12-22 M A 14,949 $10.75 51,698 D — —
3 Common Common Stock 2021-07-12 G D 10,500 $0.00 128,595 I By Spouse — — (F1) The reporting person disclaims beneficial ownership of these shares.
4 Derivative Employee Stock Option (right to buy) 2021-12-22 M D 14,949 $0.00 0 D $10.75 · — to 2022-01-05 14,949 Common Stock (F2) This option became fully exercisable on January 5, 2017.